Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Om Pharmaceutical Industries is a Jordanian pharmaceutical company based in Amman, established in 1992. The company specializes in the development, manufacturing, and marketing of a wide range of generic pharmaceutical products across various therapeutic areas, including cardiovascular, gastrointestinal, respiratory, and anti-infectives. It operates a manufacturing facility that complies with Good Manufacturing Practice (GMP) standards and serves both the domestic Jordanian market and various export markets in the Middle East and North Africa (MENA) region. The company's portfolio includes branded generics such as Omacef, Omapril, and Omastatin, and it also provides contract manufacturing services to regional partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Om Pharmaceutical Industries.